The Seattle Times

New COVID-19 vaccines approved for 2026-27 to combat latest active viruses

The FDA has approved four updated COVID-19 vaccines for the 2026-27 season, targeting current variants with availability expected soon for older adults and those with specific health risk factors.

Read the original at The Seattle Times

More audio from The Seattle Times